|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/20 Milestone Scientific Inc. 10-K 12/31/19 85:8.1M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 977K
2: EX-21.1 Subsidiaries List HTML 23K
3: EX-23.1 Consent of Experts or Counsel HTML 24K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 31K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 25K
28: R1 Document And Entity Information HTML 63K
52: R2 Consolidated Balance Sheets HTML 123K
80: R3 Consolidated Balance Sheets (Parentheticals) HTML 47K
37: R4 Consolidated Statements of Operations HTML 100K
29: R5 Consolidated Statements of Changes in HTML 156K
Stockholders' Equity
53: R6 Consolidated Statements of Cash Flows HTML 137K
81: R7 Note A - Organization and Business HTML 38K
40: R8 Note B - Going Concern and Liquidity HTML 32K
26: R9 Note C - Summary of Significant Accounting HTML 99K
Policies
18: R10 Note D - Inventories HTML 36K
44: R11 Note E - Advances on Contracts HTML 27K
75: R12 Note F - Investment in and Transactions with HTML 62K
Unconsolidated Subsidiaries
66: R13 Note G - Furniture, Fixtures and Equipment HTML 47K
17: R14 Note H - Patents HTML 49K
43: R15 Note I - Stockholders' Equity HTML 121K
74: R16 Note J - Stock Option Plans HTML 95K
64: R17 Note K - Employment Contract and Consulting HTML 34K
Agreements
16: R18 Note L - Income Taxes HTML 68K
45: R19 Note M - Segment and Geographic Data HTML 86K
77: R20 Note N - Concentrations HTML 34K
50: R21 Note O - Related Party Transactions HTML 42K
22: R22 Note P - Commitments HTML 61K
33: R23 Note Q - Pension Plan HTML 27K
76: R24 Note R - Subsequent Events HTML 29K
49: R25 Significant Accounting Policies (Policies) HTML 160K
21: R26 Note C - Summary of Significant Accounting HTML 33K
Policies (Tables)
32: R27 Note D - Inventories (Tables) HTML 35K
78: R28 Note F - Investment in and Transactions with HTML 48K
Unconsolidated Subsidiaries (Tables)
48: R29 Note G - Furniture, Fixtures and Equipment HTML 45K
(Tables)
61: R30 Note H - Patents (Tables) HTML 46K
72: R31 Note I - Stockholders' Equity (Tables) HTML 105K
46: R32 Note J - Stock Option Plans (Tables) HTML 88K
19: R33 Note L - Income Taxes (Tables) HTML 62K
62: R34 Note M - Segment and Geographic Data (Tables) HTML 88K
73: R35 Note P - Commitments (Tables) HTML 44K
47: R36 Note A - Organization and Business (Details HTML 60K
Textual)
20: R37 Note B - Going Concern and Liquidity (Details HTML 26K
Textual)
63: R38 Note C - Summary of Significant Accounting HTML 48K
Policies (Details Textual)
71: R39 Note C - Summary of Significant Accounting HTML 40K
Policies - Fair Value of Level 3 Instruments
(Details)
55: R40 Note D - Inventories (Details Textual) HTML 34K
84: R41 Note D - Inventories - Summary of Inventories HTML 35K
(Details)
34: R42 Note E - Advances on Contracts (Details Textual) HTML 25K
23: R43 Note F - Investment in and Transactions with HTML 75K
Unconsolidated Subsidiaries (Details Textual)
56: R44 Note F - Investment in and Transactions with HTML 66K
Unconsolidated Subsidiaries - Summarized Financial
Information (Unaudited) of Milestone China
(Details)
85: R45 Note G - Furniture, Fixtures and Equipment HTML 25K
(Details Textual)
35: R46 Note G - Furniture, Fixtures and Equipment - HTML 51K
Summary of Furniture, Fixtures and Equipment
(Details)
24: R47 Note H - Patents (Details Textual) HTML 52K
57: R48 Note H - Patents - Summary of Patents (Details) HTML 41K
83: R49 Note I - Stockholders' Equity (Details Textual) HTML 188K
68: R50 Note I - Stockholders' Equity - Warrants (Details) HTML 49K
60: R51 Note I - Stockholders' Equity - Summary of Shares HTML 29K
to be Issued (Details)
15: R52 Note I - Stockholders' Equity - Assumptions Used HTML 85K
to Value Warrants at Grant Date (Details)
42: R53 Note I - Stockholders' Equity - Assumptions Used HTML 53K
to Value Liability Classified Warrants Exercised
(Details)
67: R54 Note I - Stockholders' Equity - Assumption Used to HTML 101K
Value Liability Classified Warrants at Grant Date
(Details)
59: R55 Note J - Stock Option Plans (Details Textual) HTML 54K
14: R56 Note J - Stock Option Plans - Summary of Option HTML 80K
Activity for Employees and Non-employees (Details)
41: R57 Note K - Employment Contract and Consulting HTML 44K
Agreements (Details Textual)
70: R58 Note L - Income Taxes (Details Textual) HTML 42K
58: R59 Note L - Income Taxes - Deferred Tax Assets HTML 58K
(Details)
30: R60 Note L - Income Taxes - Reconciliation of the HTML 46K
Statutory Tax Rates (Details)
38: R61 Note M - Segment and Geographic Data (Details HTML 24K
Textual)
82: R62 Note M - Segment and Geographic Data - Summary by HTML 49K
Reporting and Operating Segments (Details)
54: R63 Note M - Segment and Geographic Data - Summary of HTML 38K
Operations by Geographic Area (Details)
27: R64 Note N - Concentrations (Details Textual) HTML 50K
36: R65 Note O - Related Party Transactions (Details HTML 93K
Textual)
79: R66 Note P - Commitments (Details Textual) HTML 76K
51: R67 Note P - Commitments - Lease Expense (Details) HTML 35K
25: R68 Note P - Commitments - Maturities of Lease HTML 42K
Liabilities (Details)
39: R69 Note R - Subsequent Events (Details Textual) HTML 34K
31: XML IDEA XML File -- Filing Summary XML 156K
65: EXCEL IDEA Workbook of Financial Reports XLSX 79K
8: EX-101.INS XBRL Instance -- mlss-20191231 XML 2.18M
10: EX-101.CAL XBRL Calculations -- mlss-20191231_cal XML 131K
11: EX-101.DEF XBRL Definitions -- mlss-20191231_def XML 1.58M
12: EX-101.LAB XBRL Labels -- mlss-20191231_lab XML 1.30M
13: EX-101.PRE XBRL Presentations -- mlss-20191231_pre XML 1.62M
9: EX-101.SCH XBRL Schema -- mlss-20191231 XSD 256K
69: ZIP XBRL Zipped Folder -- 0001437749-20-006563-xbrl Zip 201K
| ex_172052.htm |
Exhibit 31.1
Rule 13a-14(a)/15d-14(a) Certification
I, Leonard Osser, certify that:
|
|
1. |
I have reviewed this annual report on Form 10-K of Milestone Scientific Inc.; |
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, considering the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under the supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c. |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report the conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and |
|
|
d. |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
|
|
5. |
The registrant's other certifying officer(s) and I have disclosed, based on the most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
b. |
Any fraud, whether material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: March 30, 2020
/s/ Leonard Osser
Interim Chief Executive
Officer (Principal
Executive Officer)
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/30/20 | |||
| For Period end: | 12/31/19 | 10-K/A, 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/14/21 Milestone Scientific Inc. S-8 1/14/21 3:83K RDG Filings/FA 6/16/20 SEC UPLOAD¶ 7/15/20 2:39K Milestone Scientific Inc. 6/02/20 SEC UPLOAD¶ 7/15/20 2:44K Milestone Scientific Inc. |